Alda, J.A. et al. 2014. Expert Recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). Actas Españolas de Psiquiatría. 42, Suppl. 1 (Dec. 2014), 1–16.